Literature DB >> 29686133

Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.

Karen Krüger1, Niklas Leppkes2, Sabine Gehrke-Beck1, Wolfram Herrmann1, Engi A Algharably3, Reinhold Kreutz2, Christoph Heintze1, Iris Filler2.   

Abstract

BACKGROUND: Statins substantially reduce the risk of cardiovascular disease when taken regularly. Though statins are generally well tolerated, current studies show that one-third of patients discontinue use of statins within 2 years. A qualitative approach may improve the understanding of attitudes and behaviours towards statins, the mechanisms related to discontinuation, and how they are managed in primary care. AIM: To identify factors related to statin discontinuation and approaches for long-term statin adherence. DESIGN AND
SETTING: A qualitative study of German GPs' experiences with statin therapy in rural and urban settings in primary care.
METHOD: Semi-structured interviews (n = 16) with purposefully recruited GPs were recorded, transcribed, and analysed using qualitative content analysis.
RESULTS: Sociodemographic patient factors, the nocebo effect, patient attitudes towards primary prevention, and negative media coverage had significant impacts on statin therapy according to GPs. To overcome these barriers, GPs described useful strategies combining patient motivation and education with person-centred care. GPs used computer programs for individual risk-benefit analyses in the context of shared decision making. They encouraged patients with strong concerns or perceived side effects to continue therapy with a modified medication regimen combined with individual therapy goals.
CONCLUSION: GPs should be aware of barriers to statin therapy and useful approaches to overcome them. They could be supported by guideline recommendations that are more closely aligned to primary care as well as comprehensible patient information about lipid-lowering therapy. Future studies, exploring patients' specific needs and involving them in improving adherence behaviour, are recommended. © British Journal of General Practice 2018.

Entities:  

Keywords:  general practice; medication adherence; primary health care; qualitative research; statins

Mesh:

Substances:

Year:  2018        PMID: 29686133      PMCID: PMC6001986          DOI: 10.3399/bjgp18X696173

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  35 in total

1.  Statin discontinuation: an underestimated risk?

Authors:  Konstantinos Tziomalos; Vasilios G Athyros; Dimitri P Mikhailidis
Journal:  Curr Med Res Opin       Date:  2008-10-02       Impact factor: 2.580

Review 2.  Non-adherence to statin therapy: a major challenge for preventive cardiology.

Authors:  T R Bates; V M Connaughton; G F Watts
Journal:  Expert Opin Pharmacother       Date:  2009-12       Impact factor: 3.889

Review 3.  Predictors of statin adherence.

Authors:  Alexander Mauskop; William B Borden
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

4.  Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.

Authors:  Baris Gencer; Nicolas Rodondi; Reto Auer; Lorenz Räber; Roland Klingenberg; David Nanchen; David Carballo; Pierre Vogt; Sebastian Carballo; Philippe Meyer; Christian M Matter; Stephan Windecker; Thomas Felix Lüscher; François Mach
Journal:  Eur J Intern Med       Date:  2015-01-10       Impact factor: 4.487

5.  Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey.

Authors:  G Kees Hovingh; Shravanthi R Gandra; Jan McKendrick; Ricardo Dent; Heather Wieffer; Alberico L Catapano; Paul Oh; Robert S Rosenson; Erik S Stroes
Journal:  Atherosclerosis       Date:  2015-12-11       Impact factor: 5.162

6.  Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.

Authors:  Melissa Y Wei; Matthew K Ito; Jerome D Cohen; Eliot A Brinton; Terry A Jacobson
Journal:  J Clin Lipidol       Date:  2013-03-13       Impact factor: 4.766

7.  Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence.

Authors:  Jerry H Gurwitz; Alan S Go; Stephen P Fortmann
Journal:  JAMA       Date:  2016-11-15       Impact factor: 56.272

8.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Authors:  Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Ulrich Keil
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-04

9.  Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.

Authors:  Mohammed Al-Omran; Muhammad M Mamdani; Thomas F Lindsay; Magda Melo; David N Juurlink; Subodh Verma
Journal:  J Vasc Surg       Date:  2008-06-30       Impact factor: 4.268

10.  Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.

Authors:  Sayed H Naderi; Jonathan P Bestwick; David S Wald
Journal:  Am J Med       Date:  2012-06-27       Impact factor: 4.965

View more
  7 in total

1.  Prescribing and medical non-adherence after myocardial infarction: qualitative interviews with general practitioners in Germany.

Authors:  Christian Freier; Christoph Heintze; Wolfram J Herrmann
Journal:  BMC Fam Pract       Date:  2020-05-08       Impact factor: 2.497

2.  Adherence to lipid-lowering guidelines for secondary prevention and potential reduction in CVD events in Swedish primary care: a cross-sectional study.

Authors:  Helena Ödesjö; Staffan Björck; Stefan Franzén; Per Hjerpe; Karin Manhem; Annika Rosengren; Jörgen Thorn; Samuel Adamsson Eryd
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

3.  Effects of different statins application methods on plaques in patients with coronary atherosclerosis.

Authors:  Xia Wu; Xiao-Bo Liu; Ting Liu; Wen Tian; Yu-Jiao Sun
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

4.  Identifying Clusters of Adherence to Cardiovascular Risk Reduction Behaviors and Persistence with Medication in New Lipid-Lowering Drug Users. Impact on Healthcare Utilization.

Authors:  Sara Malo; María José Rabanaque; Lina Maldonado; Belén Moreno-Franco; Armando Chaure-Pardos; María Jesús Lallana; María Pilar Rodrigo; Isabel Aguilar-Palacio
Journal:  Nutrients       Date:  2021-02-25       Impact factor: 5.717

5.  Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media.

Authors:  Su Golder; Davy Weissenbacher; Karen O'Connor; Sean Hennessy; Robert Gross; Graciela Gonzalez Hernandez
Journal:  Drug Saf       Date:  2022-08-07       Impact factor: 5.228

6.  European Headache Federation recommendations for placebo and nocebo terminology.

Authors:  Dimos D Mitsikostas; Charlotte Blease; Elisa Carlino; Luana Colloca; Andrew L Geers; Jeremy Howick; Andrea W M Evers; Magne A Flaten; John M Kelley; Irving Kirsch; Regine Klinger; Antoinette MaassenVanDenBrink; Daniel E Moerman; Petros P Sfikakis; Lene Vase; Tor D Wager; Fabrizio Benedetti
Journal:  J Headache Pain       Date:  2020-09-25       Impact factor: 7.277

7.  Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care.

Authors:  Alexander Pate; Richard Emsley; Tjeerd van Staa
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.